Biologicals, biosimilars & vaccines Regulations in Jordan

On Sunday, 16 November 2025, we were honored by the participation of H.E. Dr. Rana Obeidat, Director General of the Jordan Food & Drug Administration (JFDA), in the opening of our workshop titled “Biologicals, Biosimilars & Vaccines Regulations in Jordan.” Her Excellency shared the JFDA’s strategic vision and highlighted the future direction of biological products in Jordan, emphasizing the importance of facilitating the introduction of innovative therapies into the Jordanian market.

The event was enriched by the presence of distinguished professionals from the JFDA, respected members of the DOA, and representatives from various multinational and local pharmaceutical companies and distributors. Their active engagement and thoughtful discussions significantly elevated the quality and outcomes of this important gathering.

Author: Diala AbuShahin

continue reading